Vitamin D receptor upregulation in alloreactive human T cells

Human Immunology

Volumn 73, Issue 7, 2012, Pages 693-698

  Joseph, Richard W ^a   Bayraktar, Ulas D ^b   Kim, Tae Kon ^b   John, St Lisa S ^c   Popat, Uday ^c   Khalili, Jahan ^c   Molldrem, Jeffrey J ^c   Wieder, Eric D ^b   Komanduri, Krishna V ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; VITAMIN D; VITAMIN D RECEPTOR;

ALLOGENEIC STEM CELL TRANSPLANTATION; ALLOIMMUNITY; ARTICLE; CELL POPULATION; CYTOKINE PRODUCTION; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; MATURATION; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; STIMULATION; T LYMPHOCYTE; UPREGULATION;

CELL DIFFERENTIATION; CELL SEPARATION; CELLS, CULTURED; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOMODULATION; ISOANTIGENS; RECEPTORS, CALCITRIOL; STEM CELL TRANSPLANTATION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; UP-REGULATION; VITAMIN D;

EID: 84862339087     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.04.019     Document Type: Article

References (33)

1. Plum L.A., DeLuca H.F. Vitamin D disease and therapeutic opportunities. Nat Rev Drug Discov 2010, 9:941.
2. Rosen C.J. Clinical practice Vitamin D insufficiency. N Engl J Med 2011, 364:248.
3. Anderson J.L., May H.T., Horne B.D., Bair T.L., Hall N.L., Carlquist J.F., et al. Relation of vitamin D deficiency to cardiovascular risk factors disease status and incident events in a general healthcare population. Am J Cardiol 2010, 106:963.
4. Wu K Feskanich D., Fuchs C.S., Willett W.C., Hollis B.W., Giovannucci E.L. A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst 2007, 99:1120.
5. Mora J.R., Iwata M., von Andrian U.H. Vitamin effects on the immune system vitamins A and D take centre stage. Nat Rev Immunol. 2008, 8:685.
6. Ritterhouse L.L., Crowe S.R., Niewold T.B., Kamen D.L., Macwana S.R., Roberts V.C., et al. Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann Rheumatic Dis 2011, 70:1569.
7. Bener A., Ehlayel M.S., Tulic M.K., Hamid Q. Vitamin D Deficiency as a Strong Predictor of Asthma in Children. Int Arch Allergy Appl Immunol 2011, 157:168.
8. Perlstein T.S., Pande R., Berliner N., Vanasse G.J. Prevalence of 25-hydroxyvitamin D deficiency in subgroups of elderly persons with anemia association with anemia of inflammation. Blood 2011, 117:2800.
9. Shanafelt T.D., Drake M.T., Maurer M.J., Allmer C., Rabe K.G., Slager S.L., et al. Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia. Blood 2010, 117:1492.
10. Joseph R.W., Alousi A., Konda B., Komanduri K., Neumann J., Trevino C., et al. High incidence of vitamin D deficiency in patients undergoing allogeneic stem cell transplantation. Am J Hematol 2011, 86:954.
11. Sproat L., Bolwell B., Rybicki L., Dean R., Sobecks R., Pohlman B., et al. Vitamin D Level after Allogeneic Hematopoietic Stem Cell Transplant. Biol Blood Marrow Transplant 2011.
12. Robien K., Strayer L.G., Majhail N., Lazovich D., Baker K.S., Smith A.R., et al. Vitamin D status among long-term survivors of hematopoietic cell transplantation. Bone Marrow Transplant 2011.
13. Baeke F., Korf H., Overbergh L., van Etten E., Verstuyf A., Gysemans C., et al. Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system. J Steroid Biochem Mol Biol 2010, 121:221.
14. Toubi E., Shoenfeld Y. The role of vitamin D in regulating immune responses. Isr Med Assoc J 2010, 12:174.
15. Von Essen M.R., Kongsbak M., Schjerling P., Olgaard K., Odum N., Geisler C. Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat Immunol 2010, 11:344.
16. Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770.
17. Adorini L., Penna G. Dendritic cell tolerogenicity a key mechanism in immunomodulation by vitamin D receptor agonists. Hum Immunol 2009, 70:345.
18. Rosenblatt J., Bissonnette A., Ahmad R., Wu Z., Vasir B., Stevenson K., et al. Immunomodulatory effects of vitamin D: implications for GVHD. Bone Marrow Transplant 2010, 45:1463.
19. Middleton P.G., Cullup H., Dickinson A.M., Norden J., Jackson G.H., Taylor P.R., et al. Vitamin D receptor gene polymorphism associates with graft-versus-host disease and survival in HLA-matched sibling allogeneic bone marrow transplantation. Bone Marrow Transplant 2002, 30:223.
20. Bogunia-Kubik K., Middleton P., Norden J., Dickinson A., Lange A. Association of vitamin D receptor polymorphisms with the outcome of allogeneic haematopoietic stem cell transplantation. Int J Immunogenet 2008, 35:207.
21. Martins S.L., St John L.S., Champlin R.E., Wieder E.D., McMannis J., Molldrem J.J., et al. Functional assessment and specific depletion of alloreactive human T cells using flow cytometry. Blood 2004, 104:3429.
22. Kim T.K., St John L.S., Wieder E.D., Khalili J., Ma Q., Komanduri K.V. Human late memory CD8+ T cells have a distinct cytokine signature characterized by CC chemokine production without IL-2 production. J Immunol 2009, 183:6167.
23. Kim T.K., Billard M.J., Wieder E.D., McIntyre B.W., Komanduri K.V. Co-engagement of alpha(4)beta(1) integrin (VLA-4) and CD4 or CD8 is necessary to induce maximal Erk1/2 phosphorylation and cytokine production in human T cells. Hum Immunol 2010, 71:23.
24. Komanduri K.V., Viswanathan M.N., Wieder E.D., Schmidt D.K., Bredt B.M., Jacobson M.A., et al. Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1. Nat Med 1998, 4:953.
25. Ozdemir E., Saliba R.M., Champlin R.E., Couriel D.R., Giralt S.A., de Lima M., et al. Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies. Bone Marrow Transplant 2007, 40:125.
26. Lanier L.L., Buck D.W., Rhodes L., Ding A., Evans E., Barney C., et al. Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen. J Exp Med 1988, 167:1572.
27. Sancho D., Gomez M., Viedma F., Esplugues E., Gordon-Alonso M., Garcia-Lopez M.A., et al. CD69 downregulates autoimmune reactivity through active transforming growth factor-beta production in collagen-induced arthritis. J Clin Invest 2003, 112:872.
28. Lowenthal J.W., Bohnlein E., Ballard D.W., Greene W.C. Regulation of interleukin 2 receptor alpha subunit (Tac or CD25 antigen) gene expression binding of inducible nuclear proteins to discrete promoter sequences correlates with transcriptional activation. Proc Natl Acad Sci USA 1988, 85:4468.
29. Anderson B.E., McNiff J., Yan J., Doyle H., Mamula M., Shlomchik M.J., et al. Memory CD4+ T cells do not induce graft-versus-host disease. J Clin Invest 2003, 112:101.
30. Chen B.J., Cui X., Sempowski G.D., Liu C., Chao N.J. Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease. Blood 2004, 103:1534.
31. Lu S.X., Alpdogan O., Lin J., Balderas R., Campos-Gonzalez R., Wang X., et al. STAT-3 and ERK 1/2 phosphorylation are critical for T-cell alloactivation and graft-versus-host disease. Blood 2008, 112:5254.
32. Wille L., Kemp M.L., Sandy P., Lewis C.L., Lauffenburger D.A. Epi-allelic Erk1 and Erk2 knockdown series for quantitative analysis of T cell Erk regulation and IL-2 production. Mol Immunol 2007, 44:3085.
33. Steinman R.M., Hawiger D., Nussenzweig M.C. Tolerogenic dendritic cells. Annu Rev Immunol 2003, 21:685.